Sector: Banking & Financial Services

Latest content

Kabushiki kokaikaisha take note: The IP-savvy activist investor may be on its way to Japan soon

Japanese investors are intervening on an increasingly regular basis to influence and shake-up corporate decision-making at the country’s largest publicly-held companies (kabushiki kokaikaisha), according to recently released research findings. The…

24 July 2015

If Qualcomm splits in two, will one half be cast as a patent troll?

There was confirmation earlier this week of what had been rumoured for some time – Qualcomm is launching a strategic review with a possible division of the business in the pipeline. That would see its very profitable patent licensing arm split off…

23 July 2015

Acacia is a bellwether NPE and well-placed to ride out current market uncertainties

Acacia Research has in many ways been a trailblazer for the NPE market. It initially pursued a large-scale approach to licensing through a volume-based strategy before shifting to a focus on marquee portfolios. It has expanded its horizons to take…

21 July 2015

The Kyle Bass pharma patent IPR strategy looks to be a lot more sophisticated and long-term than many think

Last week we published an interview with Kyle Bass, the hedge fund investor who together with Erich Spangenberg, has petitioned to challenge a series of pharmaceutical patents through the inter partes review (IPR) process at the Patent Trial and…

17 July 2015

Tsinghua’s $23 billion Micron buyout would secure China a powerful position in semiconductor patents

Tsinghua Unigroup, an investment firm affiliated with Beijing’s Tsinghua University, has offered $23 billion to purcahse Idaho-based chipmaker Micron Technology in what would be the largest Chinese acquisition of a US business to date. The deal - if…

14 July 2015

South Korean banks join forces to launch NPE with initial reserves of $89 million to spend

The Korea Development Bank (KDB) and the Industrial Bank of Korea (IBK) will each invest 50 billion won ($44.5 million) to set up a patent aggregation fund which will purchase “outstanding intellectual properties” and set about “licensing them to…

13 July 2015

Big pharma is terrified of what I am doing, but I am bringing greater clarity to the market, says Bass

This time a few months ago no-one inside the world of IP would have given Hayman Capital founder and manager Kyle Bass a second thought, unless they were one of his investors. Now, though, his name is on everyone’s lips. Since teaming up with Erich…

10 July 2015

IP-backed lending activities may have had a role in creating China’s current financial malaise

As Europe reels from deepening financial turmoil, another potential economic catastrophe is unfolding on the other side of the world.For several months now, China’s capital markets have been experiencing chaos the likes of which has rarely been…

07 July 2015

New report seeks to accelerate the development of generally accepted IP valuation principles

If IP is ever to be the asset class that many believe it should be, finding a transparent, coherent, widely accepted way to value IP holdings is absolutely crucial. Over the years, there have been a number of attempts to develop generally agreed…

03 July 2015

Patent values about to climb, heroic inventors, the US's patent failure, hope for SMEs, and much more at the IPBC

The first full day of the IPBC Global in San Francisco is now done and dusted. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights from the sessions and from the conversations…

16 June 2015

Unlock unlimited access to all IAM content